Enalapril versus lisinopril
Searched over 200M research papers
Summary
10 papers analyzed
Some studies suggest lisinopril and enalapril are equally effective and well-tolerated for heart failure and hypertension, while other studies indicate enalapril may improve arterial endothelial function and cognitive functions more effectively.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Comparative Analysis of Enalapril and Lisinopril in Hypertension and Heart Failure Treatment
Introduction to ACE Inhibitors: Enalapril and Lisinopril
Angiotensin-converting enzyme (ACE) inhibitors, such as enalapril and lisinopril, are commonly prescribed for managing hypertension and heart failure. Both drugs function by inhibiting the ACE enzyme, which plays a crucial role in blood pressure regulation. Despite their similar mechanisms, these medications exhibit distinct pharmacological properties and clinical effects.
Efficacy in Heart Failure Management
Exercise Capacity and Symptom Improvement
A study involving 278 patients with mild-to-moderate heart failure (NYHA classes II and III) compared the effects of lisinopril and enalapril on exercise capacity and heart failure symptoms. Both drugs significantly increased exercise duration and improved NYHA grading and symptoms over 12 weeks. Although there was a trend towards a greater increase in exercise duration with lisinopril, it did not reach statistical significance. Both medications were equally effective in managing heart failure symptoms and were well tolerated.
Blood Pressure Control in Hypertension
24-Hour Blood Pressure Monitoring
Several studies have compared the antihypertensive efficacy of lisinopril and enalapril using 24-hour ambulatory blood pressure monitoring (ABPM). Both drugs significantly reduced blood pressure, but lisinopril demonstrated a more pronounced effect during the latter half of the dosing interval (13-24 hours post-administration) . This suggests that lisinopril may provide more sustained blood pressure control over a 24-hour period compared to enalapril.
Office Blood Pressure Measurements
In clinical settings, lisinopril has shown a greater reduction in office systolic and diastolic blood pressure compared to enalapril. One study reported that lisinopril reduced sitting systolic and diastolic blood pressure by 25/15 mmHg, whereas enalapril achieved reductions of 17/12 mmHg after 12 weeks of treatment. This indicates that lisinopril may offer superior blood pressure-lowering effects in some patients.
Endothelial Function and Cognitive Effects
Endothelial Function
Enalapril has been found to improve arterial endothelial function, as measured by flow-mediated dilation (FMD), in newly diagnosed hypertensive patients. In contrast, lisinopril did not show significant improvements in endothelial function. This difference is attributed to the lipophilicity of enalapril, which enhances its efficacy in improving endothelial health.
Cognitive Function
Lisinopril, which crosses the blood-brain barrier, has been associated with negative effects on cognitive functions such as perceptual motor skills, complex attention, and learning. Enalapril, which does not cross the blood-brain barrier, did not exhibit these adverse cognitive effects. This suggests that enalapril may be a better option for patients concerned about cognitive side effects.
Pharmacokinetics and Tolerability
Pharmacokinetic Properties
Both enalapril and lisinopril exhibit significant ACE inhibition, but lisinopril has been shown to produce greater inhibition of plasma ACE 24 hours after dosing . Despite this, the greater ACE inhibition by lisinopril does not necessarily translate to a greater hypotensive effect.
Tolerability and Adverse Events
Both medications are generally well tolerated, with common adverse events including cough, dizziness, and hypotension. There were no significant differences in the incidence of adverse events between the two drugs .
Conclusion
In summary, both enalapril and lisinopril are effective ACE inhibitors for managing hypertension and heart failure. Lisinopril may offer more sustained blood pressure control and greater reductions in office blood pressure, while enalapril may provide superior improvements in endothelial function and have fewer cognitive side effects. The choice between these medications should be tailored to the individual patient's clinical profile and treatment goals.
Sources and full results
Most relevant research papers on this topic
